Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BCL2-interacting protein 5 (BNIP5)
- Target
- BNIP5
- Molecular classification
- BCL-2 family-like protein, Other (BCL2-interacting protein, typically classified under "Other" as it is not a classic receptor, ion channel, enzyme, transporter, or transcription factor[4][2])
01
Overview
BCL2-interacting protein 5 (BNIP5) is a mitochondrial protein that belongs to the BCL2-interacting protein (BNIP) subfamily[2][4]. It is implicated in modulating interactions among BCL2 family members, which collectively regulate apoptosis (programmed cell death)[2][1]. While the BCL2 family is central to mitochondrial membrane permeabilization and cell fate decisions, the function of BNIP5 itself has not been comprehensively defined. Its expression has been reported in some cancer types and neurodevelopmental disorders, but there is little evidence for a primary, canonical physiological or pathological role or for drug interaction[4][6][2]. BNIP5 is not currently considered an established drug target.
- Other names
- BNIP5C6orf222DKFZp779B1540protein BNIP5uncharacterized protein C6orf222
02
Mechanism of action
None known (No drugs with established mechanism of action targeting BNIP5.)
03
Biological functions
Modulation of BCL-2 family protein interactions[2]Mitochondrial-associated processes[2]Probable role in apoptosis (by analogy with other BCL-2 family members, though not directly specifically characterized[1][4][2])
04
Disease associations
Cancer (association noted in gene-disease databases for prostate cancer)[4][6]Neurodevelopmental disorders (microcephaly, seizures, developmental delay)[4]Other (Low-level experimental/clinical evidence – not a major or acknowledged disease driver)
Beyond the preview
Go deeper on BCL2-interacting protein 5 (BNIP5).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BCL2-interacting protein 5 (BNIP5).